Peisong Ma on GRK5 Polymorphism Affecting Platelets
Peisong Ma, Associate Professor at Thomas Jefferson University, shared on LinkedIn:
”Excited to share that our latest manuscript, “Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk,” is now published in the Blood Journal (online first).
In this study, we identify GRK5 as a previously unrecognized regulator of platelet PAR1 signaling and provide the first experimental evidence linking this common A→G variant to enhanced thrombin/PAR1 signaling and increased thrombus formation in vivo.
Using human GG donor platelets, iPSC-derived megakaryocytes, GRK5 inhibition, a humanized mouse model, and two preclinical models, our work connects human genetics → platelet GPCR regulation → thrombotic disease. These findings highlight GRK5 as a potential contributor to stroke and venous thromboembolism risk, with implications for future thrombophilia assessment.
Huge congratulations to my PhD students Yanki Yarman and Xuefei Zhao, and sincere thanks to our collaborators at Jefferson, CHOP, Cambridge, Mount Sinai, UPenn, and Purdue.”
Read the full article here.
Article: Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk
Authors: Yanki Yarman, Xuefei Zhao, Hyunsook Ahn, Hannah A Thomson, Amrita Sarkar, Tian Yuan, Meghan E. Roberts, Jeremy Wurtzel, Scott L Diamond, John J.G Tesmer, Deborah L French, Maurizio Tomaiuolo, Ernest Turro, William Astle, Lawrence E. Goldfinger, Steven E. McKenzie, Jeffrey Benovic, Timothy J. Stalker, Mortimer Poncz, Peisong Ma
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis
-
Jan 30, 2026, 09:57From Risk Visualization to Plaque Change: Babak Alex Vakili on CAC and CCTA Insights